1 / 6

The ATM Index – International Organizations Perspective

The ATM Index – International Organizations Perspective. Andreas Seiter The World Bank ICIUM 2011, Antalya. The World Bank and its clients. Financing (IDA, subsidized). Low-Income Countries. Research, analytics, policy advice. Middle-Income Countries. Financing (market rates).

quynh
Download Presentation

The ATM Index – International Organizations Perspective

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The ATM Index – International Organizations Perspective Andreas Seiter The World Bank ICIUM 2011, Antalya

  2. The World Bank and its clients Financing (IDA, subsidized) Low-Income Countries Research, analytics, policy advice Middle-Income Countries Financing (market rates) Overall goal: reduce poverty, increase equity

  3. Interactions with industry • IFPMA Fellowship • Open door for policy dialogue with associations and individual companies • No preference or discrimination in dialogue • No engagement on procurement related issues (which would bar manufacturers from bidding)

  4. ATM Index • A tool that serves a specific purpose – positioning companies in the global CSR debate • Increases transparency, informs discussion on CSR issues • Spotlight is on the top 10: more openness invites more scrutiny - the price of leadership?

  5. Digging deeper – testing the limits New treatment for pancreatic cancer: 1 year life extension for US$ 30,000 Ethical dilemma for payer – where to take the money from? Ethical dilemma for manufacturer – let those who can’t pay die early?

  6. Policy tools: winners and losers • Market segmentation and differential pricing • Risk-sharing, “managed entry” • Voluntary licensing • Comprehensive patient access programs • Long term donations • Effective generic drug policies with fast uptake of low cost generics • Rigid HTA for selection and value-based pricing Improved access & public benefit • Ad-hoc donations • External reference pricing • Compulsory licensing • Narrow patient access programs • Delayed registration of new drugs • Prohibitive co-payments • Indiscriminate administrative price cuts • Arbitrary rationing Higher cost to industry Italics: strategies based on industry initiative or partnership

More Related